311 related articles for article (PubMed ID: 30936196)
1. Genomic stratification and liquid biopsy in a rare adrenocortical carcinoma (ACC) case, with dual lung metastases.
McCabe MJ; Pinese M; Chan CL; Sheriff N; Thompson TJ; Grady J; Wong M; Gauthier MA; Puttick C; Gayevskiy V; Hajdu E; Wong SQ; Barrett W; Earls P; Lukeis R; Cheng YY; Lin RCY; Thomas DM; Watkins DN; Dinger ME; McCormack AI; Cowley MJ
Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30936196
[TBL] [Abstract][Full Text] [Related]
2. Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis.
Papathomas TG; Duregon E; Korpershoek E; Restuccia DF; van Marion R; Cappellesso R; Sturm N; Rossi G; Coli A; Zucchini N; Stoop H; Oosterhuis W; Ventura L; Volante M; Fassina A; Dinjens WN; Papotti M; de Krijger RR
Hum Pathol; 2016 Dec; 58():113-122. PubMed ID: 27589897
[TBL] [Abstract][Full Text] [Related]
3. Adrenocortical carcinoma and succinate dehydrogenase gene mutations: an observational case series.
Else T; Lerario AM; Everett J; Haymon L; Wham D; Mullane M; Wilson TL; Rainville I; Rana H; Worth AJ; Snyder NW; Blair IA; McKay R; Kilbridge K; Hammer G; Barletta J; Vaidya A
Eur J Endocrinol; 2017 Nov; 177(5):439-444. PubMed ID: 28819017
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of adrenocortical carcinomas.
Soon PS; Sidhu SB
Minerva Endocrinol; 2009 Jun; 34(2):137-47. PubMed ID: 19471238
[TBL] [Abstract][Full Text] [Related]
5. Coincidence of primary adrenocortical carcinoma and melanoma: three CASE reports.
Ko YL; Kumar V; Lippert J; Diaz-Cano S; Skordilis K; Kimpel O; Kircher S; Asia M; Elhassan YS; Altieri B; Ronchi CL
BMC Endocr Disord; 2023 Jan; 23(1):4. PubMed ID: 36604647
[TBL] [Abstract][Full Text] [Related]
6. Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis.
Armignacco R; Cantini G; Canu L; Poli G; Ercolino T; Mannelli M; Luconi M
J Endocrinol Invest; 2018 May; 41(5):499-507. PubMed ID: 29080966
[TBL] [Abstract][Full Text] [Related]
7. Case report: Remarkable response to a novel combination of mitotane, etoposide, paraplatin, and sintilimab in a patient with metastatic adrenocortical carcinoma.
Weng Y; Wang L; Wang XY; Fan XX; Yan L; Li ZH; Zhang SL
Front Endocrinol (Lausanne); 2023; 14():1115893. PubMed ID: 37745701
[TBL] [Abstract][Full Text] [Related]
8. Genomic and expression profiling of adrenocortical carcinoma: application to diagnosis, prognosis and treatment.
Bussey KJ; Demeure MJ
Future Oncol; 2009 Jun; 5(5):641-55. PubMed ID: 19519204
[TBL] [Abstract][Full Text] [Related]
9. Genomic and Clinical Correlates of Adrenocortical Carcinoma in an Adult Patient with Li-Fraumeni Syndrome: A Case Report.
Bondy S; Tajzler C; Hotte SJ; Kapoor A; Zbuk K; Lalani AA
Curr Oncol; 2020 Dec; 28(1):226-232. PubMed ID: 33704190
[TBL] [Abstract][Full Text] [Related]
10. Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies.
Ross JS; Wang K; Rand JV; Gay L; Presta MJ; Sheehan CE; Ali SM; Elvin JA; Labrecque E; Hiemstra C; Buell J; Otto GA; Yelensky R; Lipson D; Morosini D; Chmielecki J; Miller VA; Stephens PJ
J Clin Pathol; 2014 Nov; 67(11):968-73. PubMed ID: 25078331
[TBL] [Abstract][Full Text] [Related]
11. Assessment and management of advanced adrenocortical carcinoma using a precision oncology care model.
Elfiky AA; Krishnan Nair HK
Discov Med; 2016 Jan; 21(113):49-56. PubMed ID: 26896602
[TBL] [Abstract][Full Text] [Related]
12. [Molecular genetic markers and criteria for the prediction of adrenocortical carcinoma].
Selivanova LS; Roslyakova AA; Bogolyubova AV; Tertychnyi AS; Beltsevich DG; Abrosimov AY; Melnichenko GA
Arkh Patol; 2019; 81(5):92-96. PubMed ID: 31626211
[TBL] [Abstract][Full Text] [Related]
13. TP53 germline mutations in adult patients with adrenocortical carcinoma.
Herrmann LJ; Heinze B; Fassnacht M; Willenberg HS; Quinkler M; Reisch N; Zink M; Allolio B; Hahner S
J Clin Endocrinol Metab; 2012 Mar; 97(3):E476-85. PubMed ID: 22170717
[TBL] [Abstract][Full Text] [Related]
14. Pediatric adrenocortical carcinoma.
Ilanchezhian M; Varghese DG; Glod JW; Reilly KM; Widemann BC; Pommier Y; Kaplan RN; Del Rivero J
Front Endocrinol (Lausanne); 2022; 13():961650. PubMed ID: 36387865
[TBL] [Abstract][Full Text] [Related]
15. Adrenocortical carcinoma survival rates correlated to genomic copy number variants.
Stephan EA; Chung TH; Grant CS; Kim S; Von Hoff DD; Trent JM; Demeure MJ
Mol Cancer Ther; 2008 Feb; 7(2):425-31. PubMed ID: 18281524
[TBL] [Abstract][Full Text] [Related]
16. Combined steroidogenic characters of fetal adrenal and Leydig cells in childhood adrenocortical carcinoma.
Fujisawa Y; Sakaguchi K; Ono H; Yamaguchi R; Kato F; Kagami M; Fukami M; Ogata T
J Steroid Biochem Mol Biol; 2016 May; 159():86-93. PubMed ID: 26940356
[TBL] [Abstract][Full Text] [Related]
17. Future directions in the diagnosis and medical treatment of adrenocortical carcinoma.
Creemers SG; Hofland LJ; Korpershoek E; Franssen GJ; van Kemenade FJ; de Herder WW; Feelders RA
Endocr Relat Cancer; 2016 Jan; 23(1):R43-69. PubMed ID: 26475053
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of ferroportin1 and ceruloplasmin predicts poor prognosis in adrenocortical carcinoma.
Zhu B; Zhi Q; Xie Q; Wu X; Gao Y; Chen X; Shi L
J Trace Elem Med Biol; 2019 Dec; 56():52-59. PubMed ID: 31442954
[TBL] [Abstract][Full Text] [Related]
19. Adrenocortical carcinoma with delayed cutaneous metastasis.
Satter EK; Barnette DJ
J Cutan Pathol; 2008 Jul; 35(7):677-80. PubMed ID: 18201231
[TBL] [Abstract][Full Text] [Related]
20. Bilateral primary adrenal non-Hodgkin's lymphoma and primary adrenocortical carcinoma--review of the literature preoperative differentiation of adrenal tumors.
Ozimek A; Diebold J; Linke R; Heyn J; Hallfeldt K; Mussack T
Endocr J; 2008 Aug; 55(4):625-38. PubMed ID: 18490838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
